Corient Private Wealth LP Takes $17.74 Million Position in Corteva, Inc. $CTVA

Corient Private Wealth LP purchased a new position in shares of Corteva, Inc. (NYSE:CTVA) in the second quarter, Holdings Channel.com reports. The fund purchased 209,496 shares of the company’s stock, valued at approximately $17,742,000.

Several other large investors have also bought and sold shares of the business. William B. Walkup & Associates Inc. grew its position in Corteva by 2.9% in the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after acquiring an additional 126 shares during the last quarter. Wilkerson Advisory Group LLC lifted its holdings in shares of Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after acquiring an additional 133 shares during the last quarter. AdvisorNet Financial Inc boosted its stake in shares of Corteva by 2.4% in the 1st quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after purchasing an additional 135 shares in the last quarter. First Horizon Corp boosted its stake in shares of Corteva by 9.2% in the 1st quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after purchasing an additional 135 shares in the last quarter. Finally, Aviance Capital Partners LLC grew its holdings in shares of Corteva by 1.3% during the 1st quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after purchasing an additional 137 shares during the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Trading Up 1.9%

Shares of CTVA stock opened at $84.00 on Friday. The stock has a market cap of $56.04 billion, a price-to-earnings ratio of 55.63, a PEG ratio of 2.53 and a beta of 0.57. The stock has a 50-day moving average of $82.69 and a 200-day moving average of $80.54. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period in the previous year, the firm earned $2.20 earnings per share. The firm’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is 47.68%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CTVA. JPMorgan Chase & Co. upped their price objective on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Weiss Ratings cut shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Bank of America upped their price target on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Oppenheimer increased their price target on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Finally, Morgan Stanley raised their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.